IPOPLUS

₹380.3

▼ -1.9 -0.50%

18 Jun 2026

NSE Listed

Indraprastha Medical Corporation (INDRAMEDCO)

Volume: 1,46,244Avg Vol 1W: 2,27,836.4Avg Vol 1M: 3,75,41852W Range:₹342₹640.85
NSE BSE
₹380.3▼ 0.50%
Key Ratios
Updated 5h ago
Market Cap—
Current Price₹380.3
Previous Close₹382.2
High / Low (52w)₹640.85 / ₹342
Volume1,46,244
Avg Vol (1W)2,27,836.4
Avg Vol (1M)3,75,418
Stock P/E84.51
Book Value₹80.76
Dividend Yield—
ROE—
ROA—
Revenue (TTM)₹1,379 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹4.55
P/B—
Debt / Equity—
50 DMA₹398.38
200 DMA₹445.65
Day change-0.50%
Price Chart
₹380.3▼ 6.06% · 1Y
₹622₹3441.1Cr
2025-06-17
2026-06-12

20-day avg volume: 3.8L shares

Pros
  • Revenue grew 35% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 85.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹348 Cr₹350 Cr₹325 Cr₹334 Cr₹365 Cr₹381 Cr₹372 Cr₹365 Cr
EBITDA₹61 Cr₹59 Cr₹46 Cr₹57 Cr₹70 Cr₹68 Cr₹58 Cr₹57 Cr
Net Profit₹45 Cr₹42 Cr₹33 Cr₹41 Cr₹51 Cr₹49 Cr₹41 Cr₹42 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹831 Cr₹614 Cr₹891 Cr₹1,109 Cr₹1,262 Cr₹1,379 Cr
EBITDA₹54 Cr₹8 Cr₹82 Cr₹121 Cr₹170 Cr₹223 Cr
Net Profit₹44 Cr₹2 Cr₹59 Cr₹86 Cr₹124 Cr₹161 Cr
EPS——————
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹449 Cr₹432 Cr₹462 Cr₹555 Cr₹723 Cr₹852 Cr
Total Liabilities₹181 Cr₹159 Cr₹136 Cr₹176 Cr₹245 Cr₹255 Cr
Equity₹268 Cr₹273 Cr₹325 Cr₹379 Cr₹478 Cr₹597 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹36 Cr₹114 Cr₹154 Cr₹247 Cr₹218 Cr
Investing₹-19 Cr₹-74 Cr₹-108 Cr₹-158 Cr₹-111 Cr
Financing₹-3 Cr₹-3 Cr₹-26 Cr₹-32 Cr₹-46 Cr
Free Cash Flow₹36 Cr₹114 Cr₹154 Cr₹247 Cr₹218 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search